FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels
Contenido no disponible. Consulta la fuente original.
FDA asks Lilly, Novo to remove suicide warnings from GLP-1 labels